Inhibition of early luteal angiogenesis by gonadotropin-releasing hormone antagonist treatment in the primate

Journal of Clinical Endocrinology and Metabolism

Volumn 85, Issue 6, 2000, Pages 2339-2344

  Dickson, Sarah E ^a   Fraser, Hamish M ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BROXURIDINE; CLOPROSTENOL; GONADORELIN ANTAGONIST; PROGESTERONE; TEVERELIX;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CELL STIMULATION; CELL STRUCTURE; CONTROLLED STUDY; CORPUS LUTEUM; ENDOTHELIUM CELL; LUTEAL CELL; LUTEAL PHASE; MARMOSET; MENSTRUAL CYCLE; NONHUMAN; PRIMATE; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL;

ANIMALIA; MARMOSETS; PRIMATES;

EID: 0034455963     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.85.6.6621     Document Type: Article

References (33)

1. Control of follicular development, corpus luteum function, and the recognition of pregnancy in higher primates
2. Effects of an LH-releasing hormone antagonist on the secretion of LH, FSH, prolactin and ovarian steroids at different stages of the luteal phase in the stump-tailed macaque (Macaca arctoides)
3. Comparison of the luteolytic action of gonadotrophin-releasing hormone antagonist and cloprostenol, and the ability of human chorionic gonadotrophin and melatonin to override their luteolytic effects in the marmoset monkey
4. Suppression of corpus luteum function by the gonadotropin releasing hormone antagonist Na1 Glu: Effect of the dose and timing of human chorionic gonadotropin administration
5. Endothelial cell proliferation follows the mid-cycle luteinizing hormone surge, but not human chorionic gonadotrophin rescue, in the human corpus luteum
6. Macrophages, cell proliferation, and cell death in the human menstrual corpus luteum
7. Proliferation of microvascular endothelial cells in the primate corpus luteum during the menstrual cycle and simulated early pregnancy
8. Growth and cellular proliferation of ovine corpora lutea throughout the estrous cycle
9. Evaluahon of growth, cell proliferation, and cell death in bovine corpora lutea throughout the estrous cycle
10. Vascular endothelial growth factor is essential for corpus luteum angiogenesis
11. Suppression of luteal angiogenesis in the primate by neutralization of vascular endothelial growth factor
12. Secretion of vascular endothelial growth factor/vascular permeability factor from human luteinized granulosa cells is human chorionic gonadotrophin dependent
13. Secretion of vascular endothelial growth factor (VEGF) permeability factor (VPF) production by luteinized human granulosa cells in vitro; a paracrine signal in corpus luteum formation
14. Follicle-stimulating hormone and luteinizing hormone/chorionic gonadotropin stimulation of vascular endothelial growth factor production by macaque granulosa cells from pre- and periovulatory follicles
15. Vascular endothelial growth factor (VEGF) and angiopoietin regulation by gonadotrophin and steroids in macaque granulosa cells during the peri-ovulatory interval
16. Isolation and culture of microvascular endothelial cells from the primate corpus luteum
17. The effects of the angiogenesis inhibitor TNP-470 on luteal establishment and function in the primate
18. Inhibin secretion during the ovulatory cycle and pregnancy in the common marmoset monkey
19. Cloprostenol-induced luteolysis in the marmoset monkey (Callithrix jacchus)
20. Antarelix (EP 24332) a novel water soluble LHRH antagonist
21. Insulin-like growth factor binding protein-3 (IGFBP-3) mRNA in the endothelial cells of the primate corpus luteum
22. Angiogenesis in the female reproductive system
23. GnRH receptor mRNA expression by in situ hybridization in the primate pituitary and ovary
24. Induced luteal regression in the primate: Evidence for apoptosis and changes in c-myc protein
25. Cell death during luteal regression in the marmoset monkey (Callithrix jacchus)
26. Luteal regression in the primate: Different forms of cell death during natural and gonadotropin-releasing hormone antagonist or prostaglandin analogue-induced luteolysis
27. Suppression of luteal function by a luteinizing hormone-releasing hormone antagonist during the early luteal phase in the stump-tailed macaque monkey and the effects of subsequent administration of human chorionic gonadotropin
28. Vascular endothelial growth factor is a secreted angiogenic mitogen
29. Characterization of the receptors for vascular endothelial growth factor
30. Characterization of the receptor to vasculotropin on bovine adrenal cortex-derived capillary endothelial cells
31. Expression of vascular permeability factor/vascular endothelial growth factor by human granulosa and theca lutein cells
32. The vascular endothelial growth factor/fms-like tyrosine kinase system in human ovary during the menstrual cycle and early pregnancy
33. Expression of matrix metalloproteinase and their tissue inhibitor messenger ribonucleic acids in macaque periovulatory granulosa cells: Time course and steroid regulation